Screen Reader Mode Icon

Thank you for sharing your thoughts and experience!

This survey is designed to gather input from people with lived experience about Leqembi (lecanemab) which is a treatment for early-stage Alzheimer's Disease and Mild Cognitive Impairment. This medication is NOT a cure for the disease and would only be available to people in the early stages of Alzheimer's Disease.

The feedback from this survey will be submitted anonymously to Canada's Drug Agency (CDA) to ensure that the voice of people with lived experience is considered when evaluating the value of this treatment and recommendations for its use.
For more information about CDA, click HERE.

Question Title

* 1. What are the first 3 characters of your postal code?

Question Title

* 2. How old are you?

Question Title

* 3. Which statement best describes you:

Question Title

* 4. What is your gender?

0 of 62 answered